{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T16:20:07Z","timestamp":1783786807532,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.biopha.2015.07.040","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T20:31:25Z","timestamp":1438893085000},"page":"95-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Evaluation of the leishmanicidal and cytotoxic effects of inhibitors for microorganism metabolic pathway enzymes"],"prefix":"10.1016","volume":"74","author":[{"given":"Ademar","family":"de Mesquita Barbosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange","family":"dos Santos Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josmar Rodrigues","family":"da Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2015.07.040_bib0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0974-777X.62876","article-title":"Immunological perspectives of leishmaniasis","volume":"2","author":"Nyl\u00e9n","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"key":"10.1016\/j.biopha.2015.07.040_bib0010","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/CMR.6.3.230","article-title":"Leishmaniases of the New World: current concepts and implications for future research","volume":"6","author":"Grimaldi","year":"1993","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.biopha.2015.07.040_bib0015","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2015.07.040_bib0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1590\/S0074-02762004000300001","article-title":"Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review","volume":"99","author":"Silveira","year":"2004","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.biopha.2015.07.040_bib0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/0022-3859.926","article-title":"Recent understanding in the treatment of visceral leishmaniasis","volume":"49","author":"Rosenthal","year":"2003","journal-title":"J. Postgrad. Med."},{"key":"10.1016\/j.biopha.2015.07.040_bib0030","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/molecules14072317","article-title":"Pentavalent antimonials: new perspectives for old drugs","volume":"14","author":"Fr\u00e9zard","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2015.07.040_bib0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0166-6851(86)90001-0","article-title":"Mechanism of action of amphotericin B on Leishmania donovani promastigotes","volume":"19","author":"Saha","year":"1986","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.biopha.2015.07.040_bib0040","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4269\/ajtmh.2009.80.689","article-title":"a new and improved amphotericin B for visceral leishmaniasis","volume":"80","author":"Berman","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.biopha.2015.07.040_bib0045","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","article-title":"Leishmaniasis chemotherapy\u2014challenges and opportunities","volume":"17","author":"Croft","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.biopha.2015.07.040_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-008-0943-2","article-title":"Leishmaniasis treatment-a challenge that remains: a review","volume":"103","author":"Santos","year":"2008","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.biopha.2015.07.040_bib0055","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","article-title":"Leishmaniasis chemotherapy\u2014challenges and opportunities","volume":"17","author":"Croft","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.biopha.2015.07.040_bib0060","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2174\/1568026614666140324124807","article-title":"Structure based design, synthesis, and evaluation of potential inhibitors of steroid sulfatase","volume":"14","author":"Costa","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.biopha.2015.07.040_bib0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/1568026024607472","article-title":"Glycolysis and proteases as targets for the design of new anti-trypanosome drugs","volume":"2","author":"Lakhdar-Ghazal","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.biopha.2015.07.040_bib0070","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1016\/j.bmcl.2013.06.029","article-title":"Molecular design, synthesis and biological evaluation of 1,4-dihydro-4-oxoquinoline ribonucleosides as TcGAPDH inhibitors with trypanocidal activity","volume":"23","author":"Soares","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2015.07.040_bib0075","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2174\/1389557054023224","article-title":"Structure\u2013activity relationships for the design of small-molecule inhibitors","volume":"5","author":"Andricopulo","year":"2005","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.biopha.2015.07.040_bib0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/B978-0-12-385863-4.00004-6","article-title":"Targeting Trypanosoma cruzi sterol 14\u03b1-demethylase (CYP51)","volume":"75","author":"Lepesheva","year":"2011","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.biopha.2015.07.040_bib0085","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1017\/S0031182097001194","article-title":"Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites","volume":"114","author":"Urbina","year":"1997","journal-title":"Parasitology"},{"key":"10.1016\/j.biopha.2015.07.040_bib0090","unstructured":"L.A.A. Avelar. S\u00edntese de inibidores das enzimas cruza\u00edna e diidroorotato desidrogenase de Trypanosoma cruzi. Master Thesis [Online] Universidade de S\u00e3o Paulo, S\u00e3o Carlos, SP, April 2014. http:\/\/www.teses.usp.br\/teses\/disponiveis\/75\/75133\/tde-21112014-155848\/fr.php (accessed 31.04.15)."},{"key":"10.1016\/j.biopha.2015.07.040_bib0095","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3347\/kjp.2011.49.4.357","article-title":"Use of in vivo and in vitro systems to select Leishmania amazonensis expressing green fluorescent protein","volume":"49","author":"Costa","year":"2011","journal-title":"Korean J. Parasitol."},{"key":"10.1016\/j.biopha.2015.07.040_bib0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3347\/kjp.2009.47.3.213","article-title":"A novel organotellurium compound (RT-01) as a new antileishmanial agent","volume":"47","author":"Lima","year":"2009","journal-title":"Korean J. Parasitol."},{"issue":"1","key":"10.1016\/j.biopha.2015.07.040_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parint.2004.07.002","article-title":"Effects of hyperbaric oxygen on Leishmania amazonensis promastigotes and amastigotes","volume":"54","author":"Arrais-Silva","year":"2005","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.biopha.2015.07.040_bib0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-3083.2011.02566.x","article-title":"The influence of low oxygen on macrophage response to Leishmania infection","volume":"74","author":"Degrossoli","year":"2011","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.biopha.2015.07.040_bib0115","first-page":"6","article-title":"In silico search of energy metabolism inhibitors for alternative leishmaniasis treatment","volume":"2015","author":"Silva","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.biopha.2015.07.040_bib0120","first-page":"363","article-title":"Protease inhibitors in potential drug development for leishmaniasis","volume":"50","author":"Das","year":"2013","journal-title":"Indian J. Biochem. Biophys."},{"key":"10.1016\/j.biopha.2015.07.040_bib0125","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1016\/j.ejmech.2010.09.055","article-title":"Novel insights for dihydroorotate dehydrogenase class 1A inhibitors discovery","volume":"45","author":"Cheleski","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2015.07.040_bib0130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-4894(82)90126-6","article-title":"Leishmania mexicana: conversion of dihydroorotate to orotate in amastigotes and promastigotes","volume":"54","author":"Gero","year":"1982","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.biopha.2015.07.040_bib0135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1017\/S0031182000052574","article-title":"The enzymes of purine salvage in Trypanosoma cruzi, Trypanosoma brucei and Leishmania mexicana","volume":"87","author":"Davies","year":"1983","journal-title":"Parasitology"},{"key":"10.1016\/j.biopha.2015.07.040_bib0140","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.2174\/1381612811319140011","article-title":"Target sites for the design of anti-trypanosomatid drugs based on the structure of dihydroorotate dehydrogenase","volume":"19","author":"Pinheiro","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2015.07.040_bib0145","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1107\/S1744309106038966","article-title":"Crystallization and preliminary X-ray diffraction analysis of Leishmania major dihydroorotate dehydrogenase","volume":"62","author":"Cordeiro","year":"2006","journal-title":"Acta Crystallogr. Sect. F: Struct. Biol. Cryst. Commun."},{"key":"10.1016\/j.biopha.2015.07.040_bib0150","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pep.2006.02.010","article-title":"Cloning, expression, purification, and characterization of Leishmania major dihydroorotate dehydrogenase","volume":"48","author":"Feliciano","year":"2006","journal-title":"Protein Expression Purif."},{"key":"10.1016\/j.biopha.2015.07.040_bib0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0166-6851(95)02485-9","article-title":"Glucose transport in amastigotes and promastigotes of Leishmania mexicana mexicana","volume":"74","author":"Burchmore","year":"1995","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.biopha.2015.07.040_bib0160","first-page":"5899","article-title":"Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase: chemical library screen and antileishmanial activity","volume":"45","author":"Grant","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.biopha.2015.07.040_bib0165","doi-asserted-by":"crossref","first-page":"e3363","DOI":"10.1371\/journal.pntd.0003363","article-title":"Using a non-image-based medium-throughput assay for screening compounds targeting N-myristoylation in intracellular Leishmania amastigotes","volume":"8","author":"Paape","year":"2014","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215001845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215001845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:57:23Z","timestamp":1760093843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332215001845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":33,"alternative-id":["S0753332215001845"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2015.07.040","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the leishmanicidal and cytotoxic effects of inhibitors for microorganism metabolic pathway enzymes","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2015.07.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}